Clinical Trials on Unresectable Renal Pelvis Urothelial Carcinoma
Total 3050 results
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Hartford HospitalActive, not recruitingUrothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedUrothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire, AmiensCompletedUrothelial Carcinoma
-
Hoffmann-La RocheCompletedUrothelial CarcinomaArgentina
-
Yousef ZakhariaPfizer; University of IowaActive, not recruitingUrothelial CarcinomaUnited States
-
Germans Trias i Pujol HospitalFundació Institut Germans Trias i Pujol; Spanish Clinical Research Network... and other collaboratorsCompletedUrothelial CarcinomaSpain
-
University of Michigan Rogel Cancer CenterTerminatedUrothelial CarcinomaUnited States
-
Peking University Cancer Hospital & InstituteUnknown
-
Genentech, Inc.TerminatedUrothelial CarcinomaKorea, Republic of, United States, Canada, United Kingdom, Belgium
-
Hoosier Cancer Research NetworkNovartis PharmaceuticalsWithdrawnUrothelial Carcinoma
-
Asan Medical CenterCompletedUrothelial CarcinomaKorea, Republic of
-
National Taiwan University HospitalUnknown
-
The Affiliated Hospital of Qingdao UniversityRecruitingRenal Cell Carcinoma | Prostate Cancer | Bladder Cancer | Ureteral Calculi | Renal Calculi | Penile Cancer | Pelvic Tumor | Adrenal Tumor | Nonfunctioning Kidney | Renal Cyst | Ureteropelvic Junction Obstruction | Renal Pelvis Carcinoma | Ureteral Tumor | Duplex KidneyChina
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire de NīmesSaint-Louis Hospital, Paris, France; Institut Paoli-Calmettes; Center Eugene... and other collaboratorsRecruitingCancer | Urothelial CarcinomaFrance
-
Henan Cancer HospitalRecruitingIntraoperative Complications | Perfusion; Complications | High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Shandong TheraWisdom Biopharma Co., Ltd.RecruitingAdvanced Melanoma | Advanced Urothelial CarcinomaChina
-
National Cancer Institute (NCI)WithdrawnMetastatic NUT Carcinoma | Unresectable NUT Carcinoma
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral... and other conditionsUnited States
-
Cairo UniversityUnknownUrothelial Carcinoma Bladder | High-Risk CancerEgypt
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
National Cancer Institute (NCI)RecruitingMetastatic NUT Carcinoma | Unresectable NUT Carcinoma | Advanced NUT CarcinomaUnited States
-
Tianjin Medical University Second HospitalRecruiting
-
RemeGen Co., Ltd.CompletedAdvanced Cancer | Urothelial CarcinomaChina
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
Stanford UniversityNational Institutes of Health (NIH)WithdrawnBladder Cancer | Skin Cancers | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)United States
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
Johannes Gutenberg University MainzInterdisciplinary Center Clinical Trials (IZKS), University Medical Center...TerminatedUrothelial CarcinomaGermany
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Recruiting
-
Shanxi Province Cancer HospitalCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingUrothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire de NīmesInstitut Bergonié; Institut de cancérologie Strasbourg Europe; Centre Antoine... and other collaboratorsRecruiting
-
Changhai HospitalRenJi Hospital; West China Hospital; Tongji Hospital; Qilu Hospital of Shandong... and other collaboratorsRecruitingUrothelial CarcinomaChina
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Poland, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus
-
AstraZenecaCompletedUrothelial CarcinomaUnited States
-
Chang Gung Memorial HospitalActive, not recruitingUrothelial CarcinomaTaiwan
-
RemeGen Co., Ltd.CompletedUrothelial CarcinomaChina
-
Shanghai Zhongshan HospitalFudan University; Shanghai Jiao Tong University School of MedicineCompletedUrothelial Carcinoma
-
RemeGen Co., Ltd.Completed
-
The Netherlands Cancer Institute4SC AGActive, not recruitingUrothelial CarcinomaNetherlands
-
Matthew GalskyAstraZenecaActive, not recruitingUrothelial CarcinomaUnited States
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Genentech, Inc.Approved for marketing
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEndo PharmaceuticalsCompletedUrothelial CarcinomaUnited States